Can a One-Minute step test help heart patients get better exercise plans?
NCT ID NCT03491423
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested a short, fast step-climbing exercise in 44 people with coronary artery disease to see if it is safe and useful for measuring anaerobic fitness. Participants stepped up and down a 17.5 cm step for one minute while heart rate and pain were monitored. The goal is to develop a simple test that doctors can use to design better exercise programs for heart patients.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this test could give doctors a simple, safe way to measure anaerobic fitness in heart patients, helping tailor exercise programs.
- What could go wrong
- This is a small, early feasibility study with only 44 participants. The test may not be safe or valid for all heart patients, and results may not apply broadly.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
44 people
The number who actually took part.
- Started
-
Jun 2018
- Finished
-
May 2019
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: \- Patient who has given oral consent Adult patient (male or female) with coronary artery disease without heart failure referred for rehabilitation program Left ventricular ejection fraction (Simpson method) \> 45%. Exclusion Criteria: * Protected adult * Patient not affiliated to a national health insurance scheme * Pregnant or breastfeeding woman * Orthostatic hypotension * Severe obstructive heart disease * aortic valve narrowing * Progressive severe cardiac rhythm or conduction disorders not requiring a device, detected during the initial stress test. * intracavitary cardiac thrombus * severe pulmonary arterial hypertension (systolic pulmonary hypertension \>70mmHg) * recent venous thromboembolic history (last 3 months) * heart transplantation * associated medical condition that can predominantly impair functional and respiratory capacities (examples: unstabilized metabolic disorders such as progressive renal failure, significant asthenia related to a severe unstabilized condition such as neoplasia, systemic disease, chronic obstructive pulmonary disease...) * physical impairments of the lower limbs hindering the test, whether neurological (central or peripheral), arterial (in particular, arteriopathy of the lower limbs with systolic index \< 0.6) or orthopedic (degenerative or inflammatory rheumatism) * Treatment with Corticosteroids, Anabolics, or L-Carnitine.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Coronary artery disease without heart failure are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHU de DIJON
Dijon, 21079, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.